Janux Therapeutics, Inc.

JANX · Healthcare

$18.89

Market cap: 1.15B USDDividend yield: —
AdvanceIs it a good moment to buy Janux Therapeutics, Inc.? Ask Copenvest AIGet an Advance AI take on timing, risk, and what tracked investors are doing.Ask Copenvest AI

Loading chart…

News

Latest headlines for this stock

The FlyAug 24, 2026, 1:54 PM

Chipotle downgraded, Darden upgraded: Wall Street's top analyst calls

24/7 Wall St.Aug 24, 2026, 11:49 AM

Here Are Monday’s Top Wall Street Analyst Research Calls: AstraZeneca, Celestica, Chipotle Mexican Grill, Domino’s Pizza, Fortune Brands, Golar LNG, Jersey Mike’s Subs, Roku, and More

MT NewswiresAug 10, 2026, 11:21 AM

RBC Adjusts Price Target on Janux Therapeutics to $34 From $30, Maintains Outperform Rating

ZacksAug 6, 2026, 9:20 PM

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates